Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing
27/07/2026 22:26
BRIEF-Co-Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing July 27 (Reuters) - Co-Diagnostics Inc CODX.O:
CO-DIAGNOSTICS - AMENDS EQUITY DISTRIBUTION AGREEMENT WITH MAXIM GROUP FOR COMMON STOCK SALE - SEC FILING
CO-DIAGNOSTICS - MAY OFFER AND SELL UP TO $7.90 MILLION OF COMMON STOCK - SEC FILING
Source text: [ID:n0001493152-26-034835]
Further company coverage: CODX.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing